Gene · 2767
Papers2,923
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,923
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of the RAC/PAK Signaling Axis Enhances the Potency of MAPK Cascade Inhibitors Against Uveal Melanoma. | Biomolecules | 2025 | 41154654 | PubTator, text mining | PubMed |
| The impact of genetic variants in folliculogenesis and steroidogenesis pathways on ovarian response: a post hoc multicenter multiethnic cohort study. | J Assist Reprod Genet | 2025 | 41114748 | PubTator, text mining | PubMed |
| The emerging role of metabolic interventions in uveal melanoma. | Semin Cancer Biol | 2025 | 41110618 | PubTator, text mining | PubMed |
| Single-cell profiling deciphering cholesterol metabolism dysregulation in metastatic uveal melanoma and implicating SLC45A2 in its prognosis. | Front Immunol | 2025 | 41103423 | PubTator, text mining | PubMed |
| Ocular Melanoma: A Comprehensive Review with a Focus on Molecular Biology. | Int J Mol Sci | 2025 | 41097064 | PubTator, text mining | PubMed |
| A nomogram based on autoantibodies for noninvasive detection of AFP-negative hepatocellular carcinoma: a multicenter study. | Br J Cancer | 2025 | 41039018 | PubTator, text mining | PubMed |
| Case Report: An unexpected case of tumor regression in blue nevus melanoma following COVID-19 infection. | Front Immunol | 2025 | 41030443 | PubTator, text mining | PubMed |
| Integrating single-cell omics and materials science for uveal melanoma: from mechanistic insights to precision therapeutics. | Front Oncol | 2025 | 41001023 | PubTator, text mining | PubMed |
| A novel missense variant of the calcium-sensing receptor gene associated with familial hypocalciuric hypercalcemia. | JBMR Plus | 2025 | 40978122 | PubTator, text mining | PubMed |
| Review of the British Thoracic Society Winter Meeting 2024. | BMJ Open Respir Res | 2025 | 40953921 | PubTator, text mining | PubMed |
| Single-vessel transcriptome map pathological landscapes and reveal NR2F2-mediated smooth muscle cell phenotype acquisition in capillary malformations. | bioRxiv | 2025 | 40950147 | PubTator, text mining | PubMed |
| Inhibition of anti-apoptotic BCL2 overcomes adaptive resistance to co-targeting of the protein kinase FAK and MEK in GNAQ-driven uveal melanoma. | J Biol Chem | 2025 | 40945724 | PubTator, text mining | PubMed |
| Recent advances in S-palmitoylation and its emerging roles in human diseases. | J Hematol Oncol | 2025 | 40890756 | PubTator, text mining | PubMed |
| Unraveling the link between GNAS R201 mutation and colorectal cancer. | Sci Rep | 2025 | 40885811 | PubTator, text mining | PubMed |
| Knockdown of Derlin-1 Represses Cellular Oncogenic Activities in Uveal Melanoma, Enhances its Chemosensitivity to Cisplatin and Reduces Cancer Stem Cell Potential. | Cancer Genomics Proteomics | 2025 | 40883028 | PubTator, text mining | PubMed |
| Decoding ADGRE5: How Proteolytic Cleavage and Mechanical Forces Unleash Cellular Signals. | Cells | 2025 | 40862763 | PubTator, text mining | PubMed |
| Recent Therapies and Biomarkers in Mucinous Ovarian Carcinoma. | Cells | 2025 | 40862711 | PubTator, text mining | PubMed |
| Hypercalcemic Crisis in Pregnancy With Acute Respiratory Distress Syndrome Requiring Extracorporeal Membrane Oxygenation. | JCEM Case Rep | 2025 | 40860575 | PubTator, text mining | PubMed |
| Blue Nevi and Melanoma Arising in Blue Nevus: A Comparative Histopathological Case Series. | Reports (MDPI) | 2025 | 40843873 | PubTator, text mining | PubMed |
| Allele-specific depletion of GNAQ Q209L via siRNA or an rAAV2-shRNA vector induces selective toxicity in GNAQ Q209L uveal melanoma cells. | Mol Ther Oncol | 2025 | 40800004 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2767/papers?page=5